PF-05221304 (PF'1304), A LIVER-TARGETED ACETYL-CoA CARBOXYLASE INHIBITOR (ACCI), IN ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DEMONSTRATES ROBUST REDUCTIONS IN LIVER FAT AND ALT - PHASE 2a, DOSE-RANGING STUDY
HEPATOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要